This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Investing in the 21st Century: Return, Risk and Impact
Cole, Shawn; Gandhi, Vikram; Reimers Brumme, Caitlin LindsayTeaching Note HBS-219005-EFinanceStarting at €0.00
-
Blue Haven Initiative: The PEGAfrica Investment
Gandhi, Vikram; Reimers Brumme, Caitlin Lindsay; Migdal, AmramCase HBS-318003-EFinanceThis case examines Blue Haven Initiative (BHI), an impact investing fund and family office, and one of its investments, PEGAfrica (PEG). BHI founder Liesel Pritzker Simmons' motivations for using her family wealth to start a family office focused on impacStarting at €8.20
-
The Rise Fund: TPG Bets Big on Impact
Gandhi, Vikram; Reimers Brumme, Caitlin Lindsay; Mehta, SarahCase HBS-318041-EFinanceIt is March 2017 and TPG, a global alternative investment firm with $74 billion assets under management, has recently launched its inaugural impact investing fund-the $2 billion Rise Fund. In an effort to "take the religion out of impact investing," Mike Stone, CIO of Rise, has partnered with Chris Addy at The Bridgespan Group, a nonprofit consultancy, to develop an evidence-based methodology for quantifying the impact of prospective Rise investm...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
THE VELUX FOUNDATIONS: Selecting Impact Funds
Gandhi, Vikram; Reimers Brumme, Caitlin Lindsay; Schwalb, NathanielCase HBS-819021-EFinanceAfter much internal debate, THE VELUX FOUNDATIONS of Denmark have decided to allocate a small percentage of their investment portfolio to impact investments. Cambridge Associates, one of the leading investment advisory firms in the world, has been engaged to assist them in developing and implementing an "impact strategy." VELUX only invests in funds (as opposed to direct investments) and must now decide on fund selection criteria and on specific ...Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Goldman Sachs: Making an Imprint in Impact Investing
Cole, Shawn; Gandhi, Vikram; Reimers Brumme, Caitlin Lindsay; Schenk, LynnCase HBS-218069-EFinanceGoldman Sachs acquired Imprint Capital Advisors, a small firm that specialized in advising clients on environmental/social/governance (ESG) and impact investments. The founders sold Imprint with the belief that joining a global financial firm would help to scale impact investing, if not bring it into the mainstream. The case is set two years after the acquisition. It describes impact investing, the founding of Imprint, and its evolution from serv...Starting at €8.20
-
Background Note: Introduction to Investing for Impact
Cole, Shawn; Gandhi, Vikram; Reimers Brumme, Caitlin LindsayCase HBS-218072-EFinanceStarting at €8.20
-
Background Note: Examining the Case for Investing for Impact
Gandhi, Vikram; Cole, Shawn; Reimers Brumme, Caitlin LindsayCase HBS-218083-EFinanceStarting at €8.20